Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Thermo Fisher Scientific Inc (TMO)

Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,194,272
  • Shares Outstanding, K 375,708
  • Annual Sales, $ 42,879 M
  • Annual Income, $ 6,335 M
  • EBIT $ 7,509 M
  • EBITDA $ 10,617 M
  • 60-Month Beta 0.90
  • Price/Sales 5.04
  • Price/Cash Flow 19.15
  • Price/Book 4.24

Options Overview Details

View History
  • Implied Volatility 24.86% (-0.34%)
  • Historical Volatility 17.22%
  • IV Percentile 22%
  • IV Rank 13.62%
  • IV High 59.46% on 04/08/25
  • IV Low 19.40% on 12/06/24
  • Expected Move (DTE 5) 13.63 (2.38%)
  • Put/Call Vol Ratio 0.43
  • Today's Volume 5,320
  • Volume Avg (30-Day) 3,010
  • Put/Call OI Ratio 1.21
  • Today's Open Interest 77,064
  • Open Int (30-Day) 79,546
  • Expected Range 559.14 to 586.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 6.43
  • Number of Estimates 10
  • High Estimate 6.48
  • Low Estimate 6.38
  • Prior Year 6.10
  • Growth Rate Est. (year over year) +5.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
556.46 +2.93%
on 11/18/25
602.32 -4.91%
on 11/25/25
+5.13 (+0.90%)
since 11/05/25
3-Month
456.67 +25.42%
on 09/29/25
602.32 -4.91%
on 11/25/25
+80.17 (+16.27%)
since 09/05/25
52-Week
385.46 +48.59%
on 06/18/25
610.97 -6.25%
on 01/30/25
+51.91 (+9.97%)
since 12/05/24

Most Recent Stories

More News
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region

TMO : 572.77 (-0.43%)
Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

XLV : 153.26 (-0.42%)
TMO : 572.77 (-0.43%)
IDXX : 714.10 (-0.47%)
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated...

TMO : 572.77 (-0.43%)
1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds

1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds

RBA : 99.63 (+1.53%)
ACVA : 8.15 (+3.30%)
TMO : 572.77 (-0.43%)
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director

IDYA : 35.87 (-0.39%)
TROW : 106.58 (+0.75%)
EXAS : 101.06 (-0.07%)
ILMN : 128.96 (+0.73%)
TMO : 572.77 (-0.43%)
SERA : 3.08 (+3.36%)
IR : 79.86 (-0.16%)
MTD : 1,414.86 (-0.56%)
QTRX : 7.63 (-0.91%)
LIFE : 1.9000 (+2.70%)
Institutions Love These 3 Companies, Should You As Well?

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

LIN : 399.57 (-1.03%)
INTU : 673.63 (+1.59%)
TMO : 572.77 (-0.43%)
These 3 Stocks Are Using Buybacks to Signal Market Confidence

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

PCVX : 46.48 (+0.89%)
TTD : 40.05 (+1.78%)
TMO : 572.77 (-0.43%)
TPR : 116.30 (+1.43%)
AMZN : 229.53 (+0.18%)
Are Wall Street Analysts Predicting Thermo Fisher Scientific Stock Will Climb or Sink?

Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

XLV : 153.26 (-0.42%)
$SPX : 6,870.40 (+0.19%)
TMO : 572.77 (-0.43%)
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support fast, confident diagnoses

TMO : 572.77 (-0.43%)
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion of shares of its common stock in...

TMO : 572.77 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies...

See More

Key Turning Points

3rd Resistance Point 587.50
2nd Resistance Point 583.30
1st Resistance Point 578.03
Last Price 572.77
1st Support Level 568.56
2nd Support Level 564.36
3rd Support Level 559.09

See More

52-Week High 610.97
Last Price 572.77
Fibonacci 61.8% 524.83
Fibonacci 50% 498.21
Fibonacci 38.2% 471.60
52-Week Low 385.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar